by J.D. Lauritzen
Disclaimer: This opinion editorial (Op-Ed) is provided for informational purposes only and does not constitute legal advice. Readers should consult a qualified attorney for guidance specific to their legal issues or concerns. No attorney-client relationship is...
by Benjamin Adams
As a certified medical cannabis patient for over 13 years, I’ve experienced firsthand the complexities of navigating medical cannabis programs in both Utah and California. That journey, combined with my time editing High Times, Culture, Dope, and other cannabis...
by Benjamin Adams
With a wide range of qualifying conditions, a one-size-fits-all approach to medical cannabis dosing doesn’t work—some patients require higher doses and stronger concentrations of THC to manage their symptoms. In Utah, state law caps possession at 113 grams of...
by Benjamin Adams
Opioids, while essential for managing pain in some cases, have become a devastating force across the United States, leaving a trail of addiction and loss in their wake. The physical dependence and life-threatening risks tied to these drugs wreak havoc on families and...
by Cole Fullmer
Opioids have devastated families across Utah, mine included. But a quiet shift is happening—one story, one patient at a time. Cannabis, once villainized, is now offering something opioids never could: control, clarity, and a way forward. This isn’t about politics or...
by Cole Fullmer
Utah’s cannabis scene is evolving, and at the heart of it is Buzz, a craft flower brand that brings top-shelf genetics and a deep-rooted passion for the plant to medical cannabis patients statewide. More than just another flower label, Buzz is the personal project of...